About

About Abnova Corporation Abnova Corporation is a leading provider of research and GMP-grade reagents with over 20 years of experience in life science innovation. Our comprehensive portfolio includes antibodies, NanoAb™, recombinant proteins, ELISA kits, FISH probes, circRNA sponges, RNA laboratory reagents, and CellTx™ cell therapy solutions. We also offer integrated custom services, including recombinant antibody and protein production, VHH development, antibody engineering and humanization, assay kit development, DNA/RNA probe design, nanoCAR-T mRNA services, IVT mRNA, LNP, and analytical services, as well as orthotopic and PDX mouse models, supporting applications from basic research to preclinical development. Abnova’s new RNAutomation™ is an automated platform for mRNA synthesis and purification, supporting in vitro transcription, capping, oligo-dT and cellulose purification. Built on an open-ended Opentron Flex™ system, RNAutomation™ proprietary software, vacuum manifold module, and reagent upgrades provide a fast turn-key solution for high purity, yield, and reproducible mRNA production. RNAutomation™ is amenable to add-on modules and customized software for task-oriented missions. Abnova also provides a large portfolio of pre-validated NanoAb™ antibodies for direct sequence integration into mRNA, accelerating new RNA biologics for immunotherapy, cell therapy, and gene editing.